Atlas Trials

Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Clinical trial NCT00255177 · COMPLETED

Trial details

NCT number
NCT00255177
Sponsor
VGX Pharmaceuticals, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C Virus Infection
Start date
2005-11-01
Primary completion
2007-09-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.